Hepatitis B: Frequently Asked Questions
What’s Hepatitis B? Hepatitis B is a serious liver infection caused by the HBV (hepatitis B virus). The transmission of the HBV can happen during sexual contact (vaginal, anal or oral), through infected blood or other body fluids. Most people infected won’t display any symptoms or will experience yellowing of the skin (jaundice) before they […]
Urgent steps needed to accelerate diagnosis of hepatitis-C
Rawalpindi : Having one of the highest prevalence rate of hepatitis-C in the world, Pakistan needs to work religiously both for treatment of patients and for screening of people if we want to eliminate the disease by 2030 as has been pledged by the World Health Assembly of which Pakistan is a signatory.
Great news in hep C treatment, EPCLUSA the first pangenotypic approved in Quebec
20/03/2017 After a long waiting for, and hard discussions about pricing, we are now pleased to have the first pangenotypic (for all genotypes) approved in Quebec.
Hepatitis C Treatments, 2 new products
Here are two new medicines that have just been approved by Health Canada on August 17th and offer more therapeutic options for treating physicians, depending on the specific case of each patient.
Eliminating viral hepatitis is possible: Four lessons from the World Hepatitis Summit
By Melisa Dickie As deaths from many communicable diseases continue to decline globally, deaths caused by viral hepatitis have now surpassed all other chronic infectious diseases, including HIV/AIDS, malaria and tuberculosis.
Hep C, a new one in Quebec: ZEPATIER
Capahc is pleased to annonce good new for people living with hepatitis C. The province of Quebec is now reimbursing ZEPATIER® (elbasvir/grazoprévir) for hepatitis C patients.
The Burden of Hepatitis C